You are browsing the archive for -.

Zyngenia Completes $15 million Series A Financing Extension

Posted on: September 8, 2010 by Eamon Beltran2 Comments »

Zyngenia Inc., a Gaithersburg, Md.-based biotherapeutics company that is developing antibody drugs, completed a $15 million Series A financing extension from New Enterprise Associates.

Zyngenia Raises $10 Million

Posted on: November 5, 2009 by PEHub AdministratorNo Comments »

Zyngenia Inc., a Rockville, Md.-based pharma startup focused on antibody development, has raised $10 million in Series A funding from New Enterprise Associates.